Cited by 158Male Breast Health StudiesEstrogen and related hormone effectsSexual Differentiation and Disorders

Estrogen Excess Associated with Novel Gain-of-Function Mutations Affecting the Aromatase Gene

Open access
Shozu, Makio, Sebastian, Siby, Takayama, Kazuto, Hsu, Wei-Tong, Schultz, Roger A., Neely, Kirk, Bryant, Michael, Bulun, Serdar E.·2003·New England Journal of Medicine

Abstract

BACKGROUND: Gynecomastia of prepubertal onset may result from increased estrogen owing to excessive aromatase activity in extraglandular tissues. A gene in chromosome 15q21.2 encodes aromatase, the key enzyme for estrogen biosynthesis. Several physiologic tissue-specific promoters regulate the expression of aromatase, giving rise to messenger RNA (mRNA) species with an identical coding region but tissue-specific 5'-untranslated regions in placenta, gonads, brain, fat, and skin. METHODS: We studied skin, fat, and blood samples from a 36-year-old man, his 7-year-old son, and an unrelated 17-year-old boy with severe gynecomastia of prepubertal onset and hypogonadotropic hypogonadism caused by elevated estrogen levels. RESULTS: Aromatase activity and mRNA levels in fat and skin and whole-body aromatization of androstenedione were severely elevated. Treatment with an aromatase inhibitor decreased serum estrogen levels and normalized gonadotropin and testosterone levels. The 5'-untranslated regions of aromatase mRNA contained the same sequence (FLJ) in the father and son and another sequence (TMOD3) in the unrelated boy; neither sequence was found in control subjects. These 5'-untranslated regions normally make up the first exons of two ubiquitously expressed genes clustered in chromosome 15q21.2-3 in the following order (from telomere to centromere): FLJ, TMOD3, and aromatase. The aromatase gene is normally transcribed in the direction opposite to that of TMOD3 and FLJ. Two distinct heterozygous inversions reversed the direction of the TMOD3 or FLJ promoter in the patients. CONCLUSIONS: Heterozygous inversions in chromosome 15q21.2-3, which caused the coding region of the aromatase gene to lie adjacent to constitutively active cryptic promoters that normally transcribe other genes, resulted in severe estrogen excess owing to the overexpression of aromatase in many tissues.

Integrity signals

Registry

Crossref · 10.1056/nejmoa021559

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • All adult aromatase-deficient men have unfused epiphyses leading to linear growth into adulthood and above-average body length.

    “All adult aromatase-deficient men demonstrated a remarkably low bone mass and unfused epiphyses leading to linear growth into adulthood and above-average body length.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [21]

  • Once treated with estradiol, epiphyses closed in most aromatase-deficient men.

    “Once treated with estradiol, epiphyses closed, BMD increased and disturbances in the lipid profile improved in most of these patients.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [21]

  • All adult aromatase-deficient men demonstrated a remarkably low bone mass.

    “All adult aromatase-deficient men demonstrated a remarkably low bone mass and unfused epiphyses leading to linear growth into adulthood and above-average body length.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [21]

  • Once treated with estradiol, BMD increased in most aromatase-deficient men.

    “Once treated with estradiol, epiphyses closed, BMD increased and disturbances in the lipid profile improved in most of these patients.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [21]

  • Once treated with estradiol, disturbances in the lipid profile improved in most aromatase-deficient men.

    “Once treated with estradiol, epiphyses closed, BMD increased and disturbances in the lipid profile improved in most of these patients.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [21]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shozu, M., Sebastian, S., Takayama, K., Hsu, W.-T., Schultz, R. A., Neely, K., Bryant, M., & Bulun, S. E.
Affiliations
  • Kanazawa University (JP)
  • University of Illinois Chicago (US)
  • Tohoku University (JP)
  • Rush University Medical Center (US)
  • The University of Texas Southwestern Medical Center (US)
  • Stanford University (US)
  • Children's Hospital Los Angeles (US)
Venue
New England Journal of Medicine
Published
2003-05-08
Volume
348
Issue
19
Pages
1855-1865
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2090793581
Cited by
158
References
33
Citations by year
2026: 6 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 9 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 11 · 2013: 9 · 2012: 4
FWCI
9.16
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (CA-67167)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-38691)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Male Breast Health Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
Keywords
aromatase, gynecomastia, estrogen excess, hypogonadotropic hypogonadism, 5' untranslated region, cryptic promoter, aromatase inhibitors
MeSH terms
Anastrozole, Adipose Tissue, Adolescent, Adult, Androstenedione, Aromatase, Base Sequence, Child, Chromosome Mapping, Chromosomes, Human, Pair 15, Dexamethasone, Enzyme Inhibitors, Estradiol, Estrone, Fibroblasts, Glucocorticoids, Gynecomastia, Humans, Male, Molecular Sequence Data, Mutation, Nitriles, Promoter Regions, Genetic, RNA, Messenger, Transcription, Genetic, Triazoles, Aromatase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review